Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis

BACKGROUND AND PURPOSE: Oxidative stress has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Edaravone, a free radical scavenger, was approved as a therapeutic drug for ALS in 2015 in Japan. A phase 3 clinical trial demonstrated a smaller decline in ALS functional scale s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:eNeurologicalSci
Autori principali: Okada, Masamitsu, Yamashita, Satoshi, Ueyama, Hidetsugu, Ishizaki, Masatoshi, Maeda, Yasushi, Ando, Yukio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006910/
https://ncbi.nlm.nih.gov/pubmed/29928711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ensci.2018.05.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi